Despite the differences in the numbers and characteristics of the patient populations, ELISA methodologies, and the specific bacterial strains, both studies showed comparable IgG and IgA anti-Eg titers between healthy controls and SLE patients. The gene discussed is CD79A; the disease is systemic lupus erythematosus.